immune system
• mice fail to respond to the protective effects of pre-treatment with an encephalomyelitic peptide before EAE induction
• severe disease develops with both PLP- or MOG- induced EAE despite pre-treatment compared to controls that develop mild disease after pre-treatment with an encephalomyelitic peptide
• CD4 T cells isolated from mice in this disease model produce robust IFN-gamma and IL-17 responses when activated in the presence of MOG peptide compared to the controls that have muted responses
|